MTOR and cancer: However, given that TKIs target enzymes that participate in the activation of intracellular signaling pathways, such as the PI3K-AKT-mTOR pathway, which also regulates muscle protein synthesis [74], muscle wasting could be exacerbated in cancer patients treated with TKIs [75].